Generating Advancements in Longitudinal Analysis in X and Y Variations: Rationale, Methods, and Diagnostic Characteristics for the GALAXY Registry
- 13 August 2025
- journal article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (1) , 23-34
Abstract
Sex chromosome aneuploidies (SCAs) are a family of genetic disorders that result from an atypical number of X and/or Y chromosomes. SCAs are the most common chromosomal abnormality, affecting ~1/400 live births, yet are often underdiagnosed, leading to over‐representation of more severely impacted individuals in many clinical studies. In addition to this ascertainment bias, existing work in SCAs has also been limited by low geographic and demographic diversity. To address these limitations, we have created the Generating Advancements with Longitudinal Analysis in X and Y variations (GALAXY) Registry. Through prioritizing sustainability, transparency, and minimizing participant burden, the overarching goal of the GALAXY Registry is to improve health outcomes for individuals with SCAs by serving as an infrastructure for future SCA research based on a large, heterogeneous, and longitudinal sample. To date, GALAXY has accrued 335 verified SCA participants with an average accrual of 11.2 participants/month (6.7 47,XXY, 1.9 47,XXX, 2.0 47,XYY, 3.2 48,XXYY, 1.8 48,XXXY, and 1.3 Other). Demographic data between those identified to have SCA prenatally (predominantly cell‐free DNA screening) differ from those diagnosed postnatally for insurance status, age at enrollment, genetic test type, and reason for SCA diagnosis. Next steps include targeted recruitment of underrepresented groups (e.g., non‐47,XXY karyotypes, older adults, minoritized individuals), extraction of medical record data into the registry, international expansion, and continued engagement with the SCA community. As a collaboration between clinician investigators and the SCA community, the GALAXY Registry is a powerful resource for future patient‐centered clinical research.Keywords
Funding Information
- National Center for Advancing Translational Sciences (UM1 TR004399)
This publication has 34 references indexed in Scilit:
- How does high socioeconomic status affect maternal and neonatal pregnancy outcomes? A population-based study among American womenEuropean Journal of Obstetrics & Gynecology and Reproductive Biology: X, 2023
- Inspiring New Science to Guide Healthcare in Turner Syndrome: Rationale, design, and methods for the InsighTS RegistryAmerican Journal of Medical Genetics Part A, 2023
- Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)Genetics in Medicine, 2022
- The comorbidity landscape of 47,XXX syndrome: A nationwide epidemiologic studyGenetics in Medicine, 2022
- Early neurodevelopmental and medical profile in children with sex chromosome trisomies: Background for the prospectiveeXtraordinarYbabies study to identify early risk factors and targets for interventionAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2020
- Expanding the phenotype of Triple X syndrome: A comparison of prenatal versus postnatal diagnosisAmerican Journal of Medical Genetics Part A, 2016
- 47,XYY Syndrome: Clinical Phenotype and Timing of AscertainmentThe Journal of Pediatrics, 2013
- Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancyEuropean Journal of Human Genetics, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Prevalence and predictors of receipt of prenatal information about genetic screeningPrenatal Diagnosis, 2006